5,5-dimethyl-2-(phenylamino)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one

ID: ALA3885486

PubChem CID: 134131413

Max Phase: Preclinical

Molecular Formula: C14H14N4O

Molecular Weight: 254.29

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)C(=O)Nc2nc(Nc3ccccc3)ncc21

Standard InChI:  InChI=1S/C14H14N4O/c1-14(2)10-8-15-13(18-11(10)17-12(14)19)16-9-6-4-3-5-7-9/h3-8H,1-2H3,(H2,15,16,17,18,19)

Standard InChI Key:  PZRUBYAEITWWDH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
   19.1132  -11.5975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5259  -10.8918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7084  -10.8872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1342  -12.2602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8422  -12.6691    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5519  -12.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5491  -11.4370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1353  -11.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8426  -11.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6715  -10.2317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8585  -10.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4499   -9.4397    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2602  -12.6672    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9673  -12.2575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6723  -12.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3789  -12.2564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3781  -11.4383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6647  -11.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9611  -11.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  8  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  9  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  2  1  0
  2  8  1  0
 11 12  2  0
  6 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3885486

    ---

Associated Targets(Human)

MARK3 Tchem Serine/threonine-protein kinase c-TAK1 (2532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MARK4 Tchem MAP/microtubule affinity-regulating kinase 4 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 254.29Molecular Weight (Monoisotopic): 254.1168AlogP: 2.45#Rotatable Bonds: 2
Polar Surface Area: 66.91Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.58CX Basic pKa: 1.87CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.86Np Likeness Score: -0.69

References

1. Katz JD, Haidle A, Childers KK, Zabierek AA, Jewell JP, Hou Y, Altman MD, Szewczak A, Chen D, Harsch A, Hayashi M, Warren L, Hutton M, Nuthall H, Su HP, Munshi S, Stanton MG, Davies IW, Munoz B, Northrup A..  (2017)  Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.,  27  (1): [PMID:27816515] [10.1016/j.bmcl.2016.08.068]

Source